CV Sciences, Inc. Stock price

Equities

CVSI

US1266541028

Pharmaceuticals

Delayed OTC Markets 03:58:40 2024-03-28 pm EDT 5-day change 1st Jan Change
0.041 USD +5.13% Intraday chart for CV Sciences, Inc. +24.62% +15.82%
Sales 2021 20.05M Sales 2022 16.2M Capitalization 4.95M
Net income 2021 -15M Net income 2022 -9M EV / Sales 2021 0.63 x
Net cash position 2021 453K Net Debt 2022 917K EV / Sales 2022 0.36 x
P/E ratio 2021
-0.81 x
P/E ratio 2022
-0.44 x
Employees 43
Yield 2021 *
-
Yield 2022
-
Free-Float 99.98%
More Fundamentals * Assessed data
Dynamic Chart
1 day+5.13%
1 week+24.62%
Current month+19.53%
1 month+20.59%
3 months+20.59%
6 months-19.61%
Current year+15.82%
More quotes
1 week
0.03
Extreme 0.0333
0.04
1 month
0.03
Extreme 0.0301
0.04
Current year
0.03
Extreme 0.0301
0.04
1 year
0.03
Extreme 0.0275
0.06
3 years
0.03
Extreme 0.0263
0.51
5 years
0.03
Extreme 0.0263
6.21
10 years
0.03
Extreme 0.0263
40.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 14-06-15
Director of Finance/CFO 49 18-12-25
Members of the board TitleAgeSince
Chief Executive Officer 66 14-06-15
Director/Board Member 54 22-07-20
Director/Board Member 56 22-10-20
More insiders
Date Price Change Volume
24-03-28 0.041 +5.13% 1,459,834
24-03-27 0.039 0.00% 174,207
24-03-26 0.039 0.00% 230,380
24-03-25 0.039 +8.33% 193,563
24-03-22 0.036 +9.36% 644,858

Delayed Quote OTC Markets, March 28, 2024 at 03:58 pm EDT

More quotes
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company’s hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from business-to-business to business-to-consumer. Its +PlusCBD branded products are sold at select retail locations throughout the United States and are brands of hemp extracts in the natural products market, according to SPINS, the provider of syndicated data and insights for the natural, organic and specialty products industry. It also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based novel therapeutics. It develops, manufactures, markets and sells herbal supplements and CBD products under the brands: PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet in the Health Care market sector. The Company's plant-based food products are sold under the Cultured Foods brand.
More about the company
  1. Stock
  2. Equities
  3. Stock CV Sciences, Inc. - OTC Markets